RxDoctor Payments Data

Adam Green, MD

Pain Medicine · Bentonville, ARNPI 1861620213

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (50.8%), food and beverage and education — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Boston Scientific at 46.8% of the total. Reporting peaked in 2023 at $2,863 and has fallen 85.6% since, to $413 in 2025.

$6,592in general payments, 2019–2025

Across 133 payments — averaging $49.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$3K
  • Pacira Pharmaceuticals Incorporated$998
  • Abbott$730
  • SPR Therapeutics, Inc$517
  • Averitas Pharma Inc.$461
  • Medical Device Business Services, Inc.$300
  • plus $502 from 12 others

What the payments were for

  • Travel & lodging$3,34751%
  • Food & beverage$2,94545%
  • Education$3005%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,592 in reported general payments places this provider in the 75th percentile of 53 pain medicine providers in Arkansas.

See all pain medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$140,914
Medicare patients
462
Services billed
1,540

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen154$5,650
Pregabalin78$4,732
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen153$4,407
Gabapentin143$2,071
Lidocaine17$1,363
Tizanidine Hcl88$958
Oxycodone Hcl39$953
Tramadol Hcl67$399
Morphine Sulfate ErMorphine Sulfate23$386
Nortriptyline Hcl29$371
Duloxetine Hcl36$337
Baclofen25$303
Diclofenac Sodium18$292
Methocarbamol17$271
Cyclobenzaprine Hcl17$223

Paid to pharmacies, not to this prescriber.

Other pain medicine in Bentonville

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →